Everpure outlined a strategy for durable, accelerated growth driven by four key business areas: Core and Core AI, Modern Data Software, Scale AI, and Hyperscale Solutions. The company reaffirmed its fiscal year 2027 guidance with revenue expected between $5.03B and $5.07B, and operating income of $940M to $960M, projecting growth rates of 37-38% and 48-51% respectively. Looking ahead to fiscal year 2028, Everpure expects revenue of $7.0B to $7.3B and operating income between $1.7B and $1.9B, with significant year-over-year growth. Their strategy leverages sustained R&D investment and proprietary technology to expand into new markets, especially targeting hyperscalers and AI-native providers, aiming for new growth vectors to represent about 20% of revenue by 2030.
Everpure's expanding business model is presented here alongside Pluang's Technology-sector market snapshot as of Sep 24, 2026 04:21 WIB: Among 150 priced US tech stocks, 65 rose and 83 fell. Fastly Inc (FSLY) gained 12.46% to USD 29.33 with 99% buy orders and a typical hold time of 26 days, contrasting with AXT Inc (AXTI) which dropped 6.61% to USD 72.65 and had balanced buy/sell activity. Agora Inc (API) also rose 9.50% to USD 4.38 with a typical hold time of 31 days.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
In the week of September 14-20, 2026, Solana's decentralized exchanges (DEXs) recorded about 208 million spot trades, exceeding the New York Stock Exchange's (NYSE) 189-190 million trades. This marks the first time a blockchain-based exchange has ove...
